Elisecia Brown
Family · New Orleans, LANPI 1144650672
Payments from drug & device makers
Across 70 payments — averaging $112.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Lilly USA, LLC$702
- Gilead$618
- Johnson & Johnson$528
- Teva Pharmaceuticals USA, Inc.$484
- plus $3K from 17 others
What the payments were for
- Food & beverage$7,872100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $1,752 |
| AbbVie | 11 | $1,212 |
| Lilly USA, LLC | 7 | $702 |
| Gilead | 5 | $618 |
| Johnson & Johnson | 5 | $528 |
| Teva Pharmaceuticals USA, Inc. | 4 | $484 |
| Sanofi | 3 | $364 |
| Dexcom, Inc. | 2 | $306 |
| Viiv Healthcare Company | 2 | $224 |
| Sanofi-aventis U.S. LLC | 2 | $193 |
| Astellas Pharma US Inc | 2 | $149 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Novo Nordisk | 1 | $123 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Averitas Pharma Inc. | 1 | $122 |
| Corcept Therapeutics | 1 | $115 |
| Medtronic | 1 | $113 |
| Boehringer Ingelheim | 1 | $109 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $100 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Bayer | 1 | $94 |
| Boston Scientific | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$1,075
- AIRSUPRA$657
- FARXIGA$593
- Austedo XR$484
- BREZTRI$369
- FABRAZYME$364
- DEXCOM G7 GSS (161)$306
- Descovy$247
- XARELTO$235
- DEXCOM STELO GLUCOSE BIOSENSOR$163
- REZDIFFRA$147
- Yeztugo$126
- Humira$125
- Wegovy$123
- WAINUA$123
- DOVATO$122
- GVOKE HYPOPEN$122
- DUPIXENT$122
- MOUNJARO$122
- Qutenza$122
How this compares
$7,872 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 29 | $27,993 |
| MounjaroTirzepatide | 19 | $19,522 |
| OzempicSemaglutide | 11 | $14,361 |
| JardianceEmpagliflozin | 13 | $13,728 |
| FarxigaDapagliflozin Propanediol | 11 | $7,445 |
| Fluticasone Propionate | 52 | $629 |
| Amlodipine Besylate | 98 | $622 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 12 | $589 |
| Atorvastatin Calcium | 95 | $568 |
| Azelastine Hcl | 13 | $521 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $519 |
| Losartan Potassium | 57 | $380 |
| Chlorthalidone | 11 | $255 |
| Naproxen | 12 | $247 |
| Rosuvastatin Calcium | 13 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $702 | $47,51548 claims |
| Novo NordiskOzempic | $123 | $14,36111 claims |
| Boehringer IngelheimJardiance | $109 | $13,72813 claims |
| AstraZenecaFarxiga | $1,752 | $7,44511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.
Other family in New Orleans
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Robert ByramNew Orleans$49K
- Amy SchmittNew Orleans$48K
- Eric BabineauxNew Orleans$32K
- Cherie AlbroNew Orleans$29K
- Aimee ScroggsNew Orleans$20K
- Kelly BaquetNew Orleans$18K
- Lori LemoineNew Orleans$17K
- Jennifer GreenheckNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.